Evidence map›Paper›PMID 40595824›Full record

ArticleScientific reports2025

Value of integrated PET-IVIM MRI in predicting Ki-67 expression in newly diagnosed prostate cancer.

Liu Xiao, Yuhao Li, Yikai Xing, Lin Li

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liu Xiao *Department of Nuclear Medicine, West China Hospital of Sichuan University, No. 37. Guoxue Alley, Chengdu, 610041, Sichuan, People's Republic of China.
Yuhao Li *Department of Nuclear Medicine, West China Hospital of Sichuan University, No. 37. Guoxue Alley, Chengdu, 610041, Sichuan, People's Republic of China.
Yikai XingWest China School of Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Lin LiDepartment of Nuclear Medicine, West China Hospital of Sichuan University, No. 37. Guoxue Alley, Chengdu, 610041, Sichuan, People's Republic of China. lilinhuaxi@sina.com.

Funding

1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University ZYGD23016
6 · The paper itself

Abstract

Accurate assessment of Ki-67 expression in patients with prostate cancer (PC) is paramount. Therefore, this study aimed to assess the value of integrated Gallium-68(

Indexed as

Ki-67 AntigenMagnetic Resonance ImagingPositron-Emission TomographyProstatic NeoplasmsAgedAged, 80 and overGallium IsotopesGallium RadioisotopesHumansMaleMiddle AgedRetrospective Studiesgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesKi-67 AntigenImmunohistochemistryIVIMProstate cancerSUVmax

Identifiers

PMID40595824
PMCPMC12216096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.